First Time Loading...
J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 29.09 CNY -1.09% Market Closed
Updated: May 8, 2024
Jafron Biomedical Co Ltd
/
Cash Flow Statement
/
Cash from Operating Activities

Jafron Biomedical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jafron Biomedical Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Operating Activities
¥948.8m
CAGR 3-Years
11%
CAGR 5-Years
24%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
¥689.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
¥2.9B
CAGR 3-Years
-2%
CAGR 5-Years
41%
CAGR 10-Years
38%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
¥12.1B
CAGR 3-Years
37%
CAGR 5-Years
30%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash from Operating Activities
¥1.6B
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
18%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
¥682.8m
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jafron Biomedical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
948.8m CNY

Based on the financial report for Sep 30, 2023, Jafron Biomedical Co Ltd's Cash from Operating Activities amounts to 948.8m CNY.

What is Jafron Biomedical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
24%

Over the last year, the Cash from Operating Activities growth was -14%. The average annual Cash from Operating Activities growth rates for Jafron Biomedical Co Ltd have been 11% over the past three years , 24% over the past five years .

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.